Background : Bendamustine, a bifunctional alkylating agent with anticipated purin-like properties is active in metastatic breast cancer (MBC) patients.

苯达莫司汀，有化剂和嘌呤类似的双相能可以在转移性乳腺癌（MBC）发挥作用。